Ilana Graetz

Ilana Graetz

Auto-generated profile, based on publicly available information

Ilana Graetz

Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2016 in Medical Care
Verified
Journal Article
Closed access
IGIlana Graetz
Ilana Graetz
NGNancy Gordon
Nancy Gordon
VFVick Fung
Vick Fung
CHCourtnee Hamity
Courtnee Hamity
MRMary E. Reed
Mary E. Reed
Background: Online access to health records and the ability to exchange secure messages with physicians can improve patient engagement and outcomes; however, the digital divide could limit access to web-based portals among disadvantaged groups. Objectives: To understand whether sociodemographic differences in patient portal use for secure messaging can be explained by differences in internet access and care preferences. Research Design: Cross-sectional survey to examine the association between patient sociodemographic characteristics and internet access and care preferences; then, the association between sociodemographic characteristics and secure message use with and without adjusting for internet access and care preference. Subjects: One thousand forty-one patients with chronic conditions in a large integrated health care delivery system (76% response rate). Measures: Internet access, portal use for secure messaging, preference for in-person or online care, and sociodemographic and health characteristics. Results: Internet access and preference mediated some of the differences in secure message use by age, race, and income. For example, using own computer to access the internet explained 52% of the association between race and secure message use and 60% of the association between income and use (Sobel-Goodman mediation test, P<0.001 for both). Education and sex-related differences in portal use remained statistically significant when controlling for internet access and preference. Conclusions: As the availability and use of patient portals increase, it is important to understand which patients have limited access and the barriers they may face. Improving internet access and making portals available across multiple platforms, including mobile, may reduce some disparities in secure message use.

28 February 2018 in Journal of Cancer Survivorship
Verified
Journal Article
Closed access
PDF file
IGIlana Graetz
Ilana Graetz
CMCaitlin N. McKillop
Caitlin N. McKillop
ESEdward Stepanski
Edward Stepanski
GVGregory A. Vidal
Gregory A. Vidal
JAJaneane N. Anderson
Janeane N. Anderson
LSLee S. Schwartzberg
Lee S. Schwartzberg

2 October 2012 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
MRMary Reed
Mary Reed
JHJie Huang
Jie Huang
IGIlana Graetz
Ilana Graetz
RBRichard Brand
Richard Brand
JHJohn Hsu
John Hsu
MJMarc Jaffe
Marc Jaffe
Physicians can receive federal payments for meaningful use of complete certified electronic health records (EHRs). Evidence is limited on how EHR use affects clinical care and outcomes. To examine the association between use of a commercially available certified EHR and clinical care processes and disease control in patients with diabetes. Quasi-experimental design with outpatient EHR implementation sequentially across 17 medical centers. Multivariate analyses adjusted for patient characteristics, medical center, time trends, and facility-level clustering. Kaiser Permanente Northern California, an integrated delivery system. 169 711 patients with diabetes mellitus. Use of a commercially available certified EHR. Drug treatment intensification and hemoglobin A1c (HbA1c) and low-density lipoprotein cholesterol (LDL-C) testing and values. Use of an EHR was associated with statistically significant improvements in treatment intensification after HbA1c values of 9% or greater (odds ratio, 1.10 [95% CI, 1.05 to 1.15]) or LDL-C values of 2.6 to 3.3 mmol/L (100 to 129 mg/dL) (odds ratio, 1.06 [CI, 1.00 to 1.12]); increases in 1-year retesting for HbA1c and LDL-C levels among all patients, with the most dramatic change among patients with the worst disease control (HbA1c levels ≥9% or LDL-C levels ≥3.4 mmol/L [≥130 mg/dL]); and decreased 90-day retesting among patients with HbA1c levels less than 7% or LDL-C levels less than 2.6 mmol/L (<100 mg/dL). The EHR was also associated with statistically significant reductions in HbA1c and LDL-C levels, with the largest reductions among patients with the worst control (0.06-mmol/L [2.19-mg/dL] reduction among patients with baseline LDL-C levels ≥3.4 mmol/L [≥130 mg/dL]; P < 0.001). The EHR was implemented in a setting with strong baseline performance on cardiovascular care quality measures. Use of a commercially available certified EHR was associated with improved drug treatment intensification, monitoring, and physiologic control among patients with diabetes, with greater improvements among patients with worse control and less testing in patients already meeting guideline-recommended glycemic and lipid targets. National Institute of Diabetes and Digestive and Kidney Diseases.

1 October 2023 in Annals of Internal Medicine
Verified
Journal Article
Closed access
MRMary Reed
Mary Reed
JHJie Huang
Jie Huang
MSMadeline Somers
Madeline Somers
LHLoretta Hsueh
Loretta Hsueh
IGIlana Graetz
Ilana Graetz
AGAnjali Gopalan
Anjali Gopalan
Beyond initial COVID-19 pandemic emergency expansions of telemedicine use, it is unclear how well primary care telemedicine addresses patients' needs. To compare treatment and follow-up visits (office, emergency department, hospitalization) between primary care video or telephone telemedicine and in-person office visits. Retrospective design based on administrative and electronic health record (EHR) data. Large, integrated health care delivery system with more than 1300 primary care providers, between April 2021 and December 2021 (including the COVID-19 pandemic Delta wave). 1 589 014 adult patients; 26.5% were aged 65 years or older, 54.9% were female, 22.2% were Asian, 7.4% were Black, 22.3% were Hispanic, 46.5% were White, 21.5% lived in neighborhoods with lower socioeconomic status, and 31.8% had a chronic health condition. Treatment outcomes included medication or antibiotic prescribing and laboratory or imaging ordering. Follow-up visits included in-person visits to the primary care office or emergency department or hospitalization within 7 days. Outcomes were adjusted for sociodemographic and clinical characteristics overall and stratified by clinical area (abdominal pain, gastrointestinal concerns, back pain, dermatologic concerns, musculoskeletal pain, routine care, hypertension or diabetes, and mental health). Of 2 357 598 primary care visits, 50.8% used telemedicine (19.5% video and 31.3% telephone). After adjustment, medications were prescribed in 46.8% of office visits, 38.4% of video visits, and 34.6% of telephone visits. After the visit, 1.3% of in-person visits, 6.2% of video visits, and 7.6% of telephone visits had a 7-day return in-person primary care visit; 1.6% of in-person visits, 1.8% of video visits, and 2.1% of telephone visits were followed by an emergency department visit. Differences in follow-up office visits were largest after index office versus telephone visits for acute pain conditions and smallest for mental health. In the study setting, telemedicine is fully integrated with ongoing EHRs and with clinicians, and the study examines an insured population during the late COVID-19 pandemic period. Observational comparison lacks detailed severity or symptom measures. Follow-up was limited to 7 days. Clinical area categorization uses diagnosis code rather than symptom. In-person return visits were somewhat higher after telemedicine compared with in-person primary care visits but varied by specific clinical condition. Agency for Healthcare Research and Quality.

19 June 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MRMary E. Reed
Mary E. Reed
JHJie Huang
Jie Huang
RBRichard J. Brand
Richard J. Brand
RNRomain Neugebauer
Romain Neugebauer
IGIlana Graetz
Ilana Graetz
RGRichard Grant
Richard Grant
For patients with diabetes, many with multiple complex chronic conditions, using a patient portal can support self-management and coordination of health care services, and may impact the frequency of in-person health care visits. To examine the impact of portal access on the number of outpatient visits, emergency visits, and preventable hospitalizations. Observational study comparing patients’ visit rates with and without portal access, using marginal structural modeling with inverse probability weighting estimates to account for potential bias due to confounding and attrition. Large integrated delivery system which implemented a patient portal (2006–2007). We examined 165,447 patients with diabetes defined using clinical registries. Our study included both patients with diabetes-only and patients with multiple complex chronic conditions (diabetes plus asthma, congestive artery disease, congestive heart failure, or hypertension). We examined rates of outpatient office visits, emergency room visits, and preventable hospitalizations (for ambulatory care sensitive conditions). Access to a patient portal was associated with significantly higher rates of outpatient office visits, in both patients with diabetes only and in patients with multiple complex conditions (p<0.05). In patients with multiple complex chronic conditions, portal use was also associated with significantly fewer emergency room visits (3.9 fewer per 1,000 patients per month, p<0.05) and preventable hospital stays (0.8 fewer per 1,000 patients per month, p<0.05). In patients with only diabetes, the results were directionally consistent but not statistically significantly associated with emergency room visits and preventable hospital stays. Observational study in an integrated delivery system. Access to a patient portal can increase engagement in outpatient visits, potentially addressing unmet clinical needs, and reduce downstream health events that lead to emergency and hospital care, particularly among patients with multiple complex conditions.

1 December 2012 in Health Affairs
Verified
Journal Article
Closed access
MRMary E. Reed
Mary E. Reed
IGIlana Graetz
Ilana Graetz
VFVicki Fung
Vicki Fung
JNJoseph P. Newhouse
Joseph P. Newhouse
JHJohn Hsu
John Hsu
Consumer-directed health plans are plans with high deductibles that typically require patients to bear no out-of-pocket costs for preventive care, such as annual physicals or screening tests, in order to ease financial barriers and encourage patients to seek such care. We surveyed people in California who had a consumer-directed health plan and found that fewer than one in five understood that their plan exempted preventive office visits, medical tests, and screenings from their deductible, meaning that this care was free or had a modest copayment. Roughly one in five said that they had delayed or avoided a preventive office visit, test, or screening because of cost. Those who were confused about the exemption were significantly more likely to report avoiding preventive visits because of cost concerns. Special efforts to educate consumers about preventive care cost-sharing exemptions may be necessary as more health plans, including Medicare, adopt this model.